Skip to main content

Table 1 Baseline characteristics of patients with severe haemophilia B in CHESS II

From: Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe

  All patients
(n = 75)
SHL
(n = 42)
EHL
(n = 33)
Age, mean (SD) 36.2 (15.97) 33.7 (14.26) 39.3 (17.66)
Weight, kg, mean (SD) 77.3 (11.07) 74.0 (11.58) 79.9 (10.06)
Country, n (%)    
 UK 22 (29) 15 (36) 7 (21)
 Italy 17 (23) 11 (26) 6 (18)
 Spain 15 (20) 9 (21) 6 (18)
 France 11 (15) 4 (10) 7 (21)
 Germany 10 (13) 3 (7) 7 (21)
Medical history, n (%)    
 Anxiety 9 (12) 5 (12) 4 (12)
 Depression 5 (7) 4 (10) 1 (3)
 HIV 1 (1) 0 1 (3)
 Hepatitis B 4 (5) 3 (7) 1 (3)
 Hepatitis C 9 (12) 4 (10) 5 (15)
FIX prophylaxis treatment, n (%)    
 EHL 33 (44) 33 (100)
 SHL 42 (56) 42 (100)
Primary FIX prophylaxis, n (%) 57 (76) 29 (69) 28 (85)
Secondary FIX prophylaxis, n (%) 18 (24) 13 (31) 5 (15)
  1. EHL, extended half-life; FIX, Factor IX; HIV, human immunodeficiency virus; SD, standard deviation; SHL, short half-life
  2. Proportions may not sum to 100% due to rounding